# Amanda Psyrri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/amanda-psyrri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,418 |
| Field | Head and Neck Cancer Studies |
| h-index | 59 |
| i10-index | 194 |
| Last Known Institution | National and Kapodistrian University of Athens |
| OpenAlex ID | https://openalex.org/A5063134810 |
| ORCID iD | https://orcid.org/0000-0002-4321-766X |
| Works | 602 |

## Researcher papers

- [Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-alone-or-with-chemotherapy-versus-cetuximab-with-chemotherapy-for/)
- [Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis](https://scholariq.org/papers/prognostic-role-of-pretreatment-plasma-fibrinogen-in-patients-with-solid-tumors/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [National and Kapodistrian University of Athens](https://scholariq.org/institutions/national-and-kapodistrian-university-of-athens/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.